Ketone Plasma Kinetics After Oral Intake Of Different MCT
NCT ID: NCT03603782
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2018-06-04
2024-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ketone Plasma Kinetics After Oral Intake of Different Ketogenic Formulae
NCT05058157
Comparing the Ketogenic Effect of Coconut Oil and Different MCTs
NCT02679222
Effects of Faba Bean Fractions as Ingredients in Novel Food Products on Glycemia, Appetite and Metabolic Control
NCT02666586
Acceptability and Tolerability of Ketone Supplements and Effects of BHB Concentrations in Young Adults
NCT05390385
Metabolomic Signature of Exogenous Ketosis
NCT05699707
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
protein 5%
5%
protein 10%
10%
protein 15%
15%
B2: only breakfast (no product)
only breakfast
C2: 5% protein with breakfast
C2: 5% protein consumed with breakfast
D2: 5% protein 30 min before breakfast
D2: 5% protein consumed 30 min before breakfast
2
2.5% protein
2.5%
protein 10%
10%
protein 15%
15%
A2: Peptamen 1.5 Vanilla without Breakfast
Peptamen withoug breakfast
C2: 5% protein with breakfast
C2: 5% protein consumed with breakfast
D2: 5% protein 30 min before breakfast
D2: 5% protein consumed 30 min before breakfast
3
2.5% protein
2.5%
protein 5%
5%
protein 15%
15%
A2: Peptamen 1.5 Vanilla without Breakfast
Peptamen withoug breakfast
B2: only breakfast (no product)
only breakfast
D2: 5% protein 30 min before breakfast
D2: 5% protein consumed 30 min before breakfast
4
2.5% protein
2.5%
protein 5%
5%
protein 10%
10%
A2: Peptamen 1.5 Vanilla without Breakfast
Peptamen withoug breakfast
B2: only breakfast (no product)
only breakfast
C2: 5% protein with breakfast
C2: 5% protein consumed with breakfast
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
2.5% protein
2.5%
protein 5%
5%
protein 10%
10%
protein 15%
15%
A2: Peptamen 1.5 Vanilla without Breakfast
Peptamen withoug breakfast
B2: only breakfast (no product)
only breakfast
C2: 5% protein with breakfast
C2: 5% protein consumed with breakfast
D2: 5% protein 30 min before breakfast
D2: 5% protein consumed 30 min before breakfast
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Healthy men and women, based on the medical screening visit and medical history
3. BMI in the normal and overweight range 18.5 ≤ BMI ≤ 27.
4. Able to understand and to sign a written informed consent prior to study entry
Exclusion Criteria
2. Any medication impacting dietary fat absorption and metabolism or impacting postprandial glucose and insulin response, to the opinion of the medical expert
3. Pregnancy (on anamnesis) and/or lactation
4. Known food allergy and food intolerance
5. Individuals undergoing either dietary or exercise mediated weight loss program prescribed by a health care professional
6. Individuals under ketogenic diets, or taking regular ketones products such as MCT, ketone esters or ketone salts (calcium, magnesium, sodium, potassium)
7. Alcohol intake higher than 2 servings per day. A serving is 0.4 dl of strong alcohols, 1 dl of red or white wine, or 3 dl of bier
8. Having given blood within the last month, or willing to make a blood donation until one month following the end of the study
9. Participant having a hierarchical link with the research team members
10. Not expected to follow the protocol.
11. Smokers unable to stop for the day of the visit
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société des Produits Nestlé (SPN)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maurice Beaumont, dr
Role: STUDY_DIRECTOR
Nestec Ltd.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Metabolic Unit
Lausanne, Canton of Vaud, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18.03.NRC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.